ZA914227B - Novel protein - Google Patents

Novel protein

Info

Publication number: ZA914227B
Authority: ZA; South Africa
Prior art keywords: protein; novel protein; relates; malaria; vaccination
Prior art date: 1990-06-06

Application number

ZA914227A

Other languages

English (en)

Inventor

Johannes Gerardus Schoenmakers

Gerardus Ghislain Sch Johannes

Rudolph Nicolaas Hendr Konings

Nicolaas Hendrik Konin Rudolph

Inge Irma Maria Domini Moelans

Irma Maria Dominique Moel Inge

Original Assignee

Univ Nijmegen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-06

Filing date

1991-06-04

Publication date

1992-03-25

1991-06-04 Application filed by Univ Nijmegen filed Critical Univ Nijmegen

1992-03-25 Publication of ZA914227B publication Critical patent/ZA914227B/xx

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
102000004169 proteins and genes Human genes 0.000 title abstract 3
102000018697 Membrane Proteins Human genes 0.000 abstract 1
108010052285 Membrane Proteins Proteins 0.000 abstract 1
241000223960 Plasmodium falciparum Species 0.000 abstract 1
238000010367 cloning Methods 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
201000004792 malaria Diseases 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Toxicology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Cell Biology (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

ZA914227A 1990-06-06 1991-06-04 Novel protein ZA914227B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909012580A GB9012580D0 (en)	1990-06-06	1990-06-06	Novel protein

Publications (1)

Publication Number	Publication Date
ZA914227B true ZA914227B (en)	1992-03-25

Family

ID=10677137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA914227A ZA914227B (en)	1990-06-06	1991-06-04	Novel protein

Country Status (16)

Country	Link
EP (1)	EP0597843B1 (pt)
JP (1)	JP3066385B2 (pt)
KR (1)	KR930700544A (pt)
AT (1)	ATE176671T1 (pt)
AU (1)	AU641779B2 (pt)
CA (1)	CA2084673C (pt)
DE (1)	DE69130895T2 (pt)
DK (1)	DK0597843T3 (pt)
ES (1)	ES2127728T3 (pt)
GB (1)	GB9012580D0 (pt)
GR (1)	GR3029665T3 (pt)
IE (1)	IE911924A1 (pt)
NZ (1)	NZ238401A (pt)
PT (1)	PT97876B (pt)
WO (1)	WO1991018922A1 (pt)
ZA (1)	ZA914227B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9202026A (nl) *	1992-11-20	1994-06-16	Stichting Katholieke Univ	Recombinant nuclëinezuur, daardoor gecodeerd polypeptide materiaal en daarop gebaseerd transmissie-blokkerend vaccin ter bestrijding van de malariaparasiet Plasmodium falciparum.
GB9616351D0 (en) *	1996-08-02	1996-09-11	Smithkline Beecham Biolog	Vaccine composition
US6593463B1 (en)	1997-10-20	2003-07-15	Genzyme Transgenics Corporation	Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems
US6828416B1 (en)	1998-08-21	2004-12-07	The United States Of America As Represented By The Department Of Health And Human Services	Recombinant multivalent malarial vaccine against Plasmodium falciparum
GB0513421D0 (en)	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
CL2008002361A1 (es)	2007-08-13	2009-08-07	Glaxosmithkline Biologicals Sa	Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
US20120244178A1 (en) *	2011-03-25	2012-09-27	Denise Doolan	Plasmodium falciparum antigens

1990
- 1990-06-06 GB GB909012580A patent/GB9012580D0/en active Pending
1991
- 1991-06-01 DK DK91910355T patent/DK0597843T3/da active
- 1991-06-01 EP EP91910355A patent/EP0597843B1/en not_active Expired - Lifetime
- 1991-06-01 KR KR1019920703106A patent/KR930700544A/ko not_active Abandoned
- 1991-06-01 DE DE69130895T patent/DE69130895T2/de not_active Expired - Lifetime
- 1991-06-01 WO PCT/EP1991/001006 patent/WO1991018922A1/en not_active Ceased
- 1991-06-01 JP JP3509543A patent/JP3066385B2/ja not_active Expired - Lifetime
- 1991-06-01 ES ES91910355T patent/ES2127728T3/es not_active Expired - Lifetime
- 1991-06-01 AT AT91910355T patent/ATE176671T1/de not_active IP Right Cessation
- 1991-06-01 CA CA002084673A patent/CA2084673C/en not_active Expired - Lifetime
- 1991-06-01 AU AU79629/91A patent/AU641779B2/en not_active Ceased
- 1991-06-04 ZA ZA914227A patent/ZA914227B/xx unknown
- 1991-06-05 PT PT97876A patent/PT97876B/pt not_active IP Right Cessation
- 1991-06-05 IE IE192491A patent/IE911924A1/en unknown
- 1991-06-05 NZ NZ238401A patent/NZ238401A/en unknown
1999
- 1999-03-12 GR GR990400749T patent/GR3029665T3/el unknown

Also Published As

Publication number	Publication date
EP0597843A1 (en)	1994-05-25
JP3066385B2 (ja)	2000-07-17
PT97876A (pt)	1992-04-30
DE69130895D1 (de)	1999-03-25
IE911924A1 (en)	1991-12-18
CA2084673A1 (en)	1991-12-07
NZ238401A (en)	1994-01-26
GR3029665T3 (en)	1999-06-30
WO1991018922A1 (en)	1991-12-12
AU641779B2 (en)	1993-09-30
AU7962991A (en)	1991-12-31
KR930700544A (ko)	1993-03-15
DK0597843T3 (da)	1999-09-20
EP0597843B1 (en)	1999-02-10
ES2127728T3 (es)	1999-05-01
GB9012580D0 (en)	1990-07-25
PT97876B (pt)	1998-10-30
JPH06500990A (ja)	1994-01-27
CA2084673C (en)	2002-07-30
ATE176671T1 (de)	1999-02-15
DE69130895T2 (de)	1999-09-30

Similar Documents

Publication	Publication Date	Title
NO20111324A1 (no)	2011-09-29	Rekombinant MVA-virus
AU592749B2 (en)	1990-01-25	Cloning of dna for protozoal antigens
CA2231603A1 (en)	1997-04-24	Chicken interleukin-15 and uses thereof
CA2132836A1 (en)	1993-09-30	Immunization by inoculation of dna transcription unit
EP0759935A4 (en)	1999-07-07	RECOMBINANT PAPILLOMAVIRUS L1
DE69837390D1 (de)	2007-05-03	Rekombinanter schweine adenovirus vektor
DE3854213D1 (de)	1995-08-31	Analoge der Untereinheit des von rekombinanter DNS abgeleiteten Bordetella-Toxins.
FR2697022B1 (fr)	1994-12-16	Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
FR2744724B1 (fr)	2002-08-02	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
ATE435661T1 (de)	2009-07-15	Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel
DE3853139D1 (de)	1995-03-30	Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
WO2005040206A8 (en)	2005-06-30	Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it
GB9012580D0 (en)	1990-07-25	Novel protein
ITMI913092A1 (it)	1993-05-20	Vaccino di poxvirus ricombinante del virus del morbillo
IL97013A (en)	1997-03-18	Immunoreactive protein of an eimeria merozoite surface antigen, dna encodidng it, the production of the protein and its use as a vaccine
MXPA02005506A (es)	2004-09-10	Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
MY105313A (en)	1994-09-30	Malaria vaccine.
AU3763789A (en)	1989-11-29	Gene encoding 25 kDa surface protein of zygotes and ookinetes of plasmodium
EP0584201A4 (en)	1997-03-19	Transmission-blocking vaccine against malaria
WO2002055104A3 (en)	2003-03-13	Acne vaccine
WO1998040497A3 (en)	1998-12-10	An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
SE9702242D0 (sv)	1997-06-12	Vaccine compositions V
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
ATE97693T1 (de)	1993-12-15	Plasmodium-merozoit-rhoptry-antigen und derivate.
AR245782A1 (es)	1994-02-28	Procedimiento para preparar gbp 130 h